Achucarro Basque Center for Neuroscience -ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive

    Frontiers in Cellular Neuroscience, Vol. 18

2022

  1. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

2021

  1. Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation

    npj Parkinson's Disease, Vol. 7, Núm. 1

  2. Fluorine Labeling of Nanoparticles and in Vivo 19F Magnetic Resonance Imaging

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 11, pp. 12941-12949

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease

    Nature Communications, Vol. 11, Núm. 1

  2. In vivo PET Imaging of Gliogenesis After Cerebral Ischemia in Rats

    Frontiers in Neuroscience, Vol. 14

  3. In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke

    Theranostics, Vol. 11, Núm. 1, pp. 410-425

  4. Neurobiological Mechanisms of Autism Spectrum Disorder and Epilepsy, Insights from Animal Models

    Neuroscience, Vol. 445, pp. 69-82

2018

  1. Mangiferin and morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by Amyloid Beta Oligomers

    Oxidative Medicine and Cellular Longevity, Vol. 2018

2017

  1. Building Bridges through Science

    Neuron

2013

  1. 1–42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death

    Translational Psychiatry, Vol. 3, Núm. 1